A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome.

Trial Profile

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 May 2013

At a glance

  • Drugs Atopaxar (Primary)
  • Indications Acute coronary syndromes; Embolism and thrombosis
  • Focus Adverse reactions
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 30 Aug 2010 Results have been published in the European Heart Journal.
    • 30 Aug 2010 Results have been presented at ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 24 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top